Voclosporin Improves Renal Outcomes in Active Lupus Nephritis
Patients with active lupus nephritis who received voclosporin experienced a superior renal response as patients receiving standard of care.
Patients with active lupus nephritis who received voclosporin experienced a superior renal response as patients receiving standard of care.
A study of patients at a community-based nephrology practice found a higher cardiovascular disease prevalence with hyperuricemia or gout.
Febuxostat well tolerated in dialysis-dependent patients with gout.
In a randomized, placebo-controlled trial that enrolled patients with chronic kidney disease stages 3 and 4, sodium bicarbonate did not significant affect sit-to-stand time or bone mineral density.
A study found that renal arteriosclerosis develops 2 decades earlier in patients with lupus nephritis compared with healthy age-matched controls.